What is the enterprise number of EYED PHARMA?

The enterprise number of EYED PHARMA is BE0508599605.

What is the address of EYED PHARMA?

The registered office of EYED PHARMA is located at Rue Louis Plescia 9, 4102 Seraing.

When was EYED PHARMA founded?

EYED PHARMA was founded on 20 December 2012.

What is the main activity of EYED PHARMA?

The main activity of EYED PHARMA is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).

Does EYED PHARMA have a website?

Yes, EYED PHARMA has a website at eyedpharma.com.

Does EYED PHARMA have an online shop?

Yes, EYED PHARMA has an online shop.

Is EYED PHARMA active on social media?

Yes, EYED PHARMA is active on Facebook, Linkedin.

How much profit did EYED PHARMA make in 2024?

EYED PHARMA recorded a loss after taxes of € 6,940,910 in financial year 2024.

What is the revenue of EYED PHARMA?

In its most recent annual accounts (2024), EYED PHARMA reported revenue of € 11,761,713.

How many employees does EYED PHARMA have?

According to the 2024 annual accounts, EYED PHARMA has 33.5 full-time equivalents (FTE).

Where can I find the annual accounts of EYED PHARMA?

EYED PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.

Who are the directors of EYED PHARMA?

According to the 2024 annual accounts, the directors of EYED PHARMA are: Jean Marie Rakic, CORPAR, Sparaxis, NOSHAQ, Oukelos, Carolyn Myers, Fund +, Qbic Venture Partners II.

EYED PHARMA (Public Limited) - Seraing (4102) - BE0508599605

Financials

Financial year 2024

Worth noting

A loss two years in a row.
The team shrank two years in a row.

Revenue

€ 11.8 million

Profit

Caution

€ -6.9 million

▼ 15% vs 2023

Debts

Low

€ 19.5 million

▲ 89% vs 2023

EYED PHARMA from Seraing, company number BE0508599605, closed financial year 2024 with a result of € -6.9 million after tax. For that financial year EYED PHARMA recorded revenue of € 11.8 million and equity of € 22.8 million. Compared with financial year 2023, the result moved from € -6 million to € -6.9 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2025.

What happened at EYED PHARMA?

What happened at EYED PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2027 Fund + stepped down as director. NBB
2026 Carolyn Myers stepped down as director. NBB
2025 CORPAR stepped down as director. NBB
2025 Sparaxis stepped down as director. NBB
Jul 28, 2025 New annual accounts for financial year 2024: loss of € 6.9 million. Source: NBB ↗
2025 Jean Marie Rakic stepped down as director. NBB
2025 NOSHAQ stepped down as director. NBB
2025 Oukelos stepped down as director. NBB

In short

From € 4.7 million loss in 2021 to € 6.9 million loss in 2024.

On average € 7,600 of value added per employee in 2024.

Original PDFs at the National Bank ↗

A new publication or filing at EYED PHARMA? We notify you, reason included.

Follow EYED PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New

Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.